Another systematic review published alongside found only limited, low-strength evidence that cannabis alleviates neuropathic pain and insufficient evidence for other types of pain. An editorial notes that the conclusions of both systematic reviews largely echo a recent comprehensive review on these and other health effects of cannabis, suggesting a growing consensus in the field, that there is little high-quality evidence from which to draw firm conclusions about the efficacy of cannabis and cannabinoid products for treating pain and posttraumatic stress disorder. It suggests that even if future studies reveal a clear lack of substantial benefit, legislation is unlikely to remove these conditions from the lists of indications for medical cannabis in states in US where medical cannabis is legal.